These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7596959)

  • 1. Pharmacotoxicological aspects of levosulpiride.
    Rossi F; Forgione A
    Pharmacol Res; 1995 Feb; 31(2):81-94. PubMed ID: 7596959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosulpiride: a review of its clinical use in psychiatry.
    Mucci A; Nolfe G; Maj M
    Pharmacol Res; 1995 Feb; 31(2):95-101. PubMed ID: 7596960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levosulpiride in the management of functional dyspepsia and delayed gastric emptying].
    Serra J
    Gastroenterol Hepatol; 2010 Oct; 33(8):586-90. PubMed ID: 20850200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride: a review of its use in the management of schizophrenia.
    Curran MP; Perry CM
    Drugs; 2001; 61(14):2123-50. PubMed ID: 11735643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosulpiride in premature ejaculation.
    Hussain SJ; Hameed A; Nazar HS; Javid A; Shah Y; Hameed W; Miran MS
    J Ayub Med Coll Abbottabad; 2010; 22(4):124-6. PubMed ID: 22455278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
    Gordon JH; Clopton JK; Curtin JC; Koller WC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):223-8. PubMed ID: 3575347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia.
    Distrutti E; Fiorucci S; Hauer SK; Pensi MO; Vanasia M; Morelli A
    Aliment Pharmacol Ther; 2002 Mar; 16(3):613-22. PubMed ID: 11876717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosulpiride and Serum Prolactin Levels.
    Kuchay MS; Mithal A
    Indian J Endocrinol Metab; 2017; 21(2):355-358. PubMed ID: 28459037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosulpiride-induced movement disorders.
    Shin HW; Kim MJ; Kim JS; Lee MC; Chung SJ
    Mov Disord; 2009 Nov; 24(15):2249-53. PubMed ID: 19795476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulpiride: assessment of a pharmacologically and chemically distinct neuroleptic.
    Rich TD
    Med Hypotheses; 1984 May; 14(1):69-81. PubMed ID: 6146915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterisation of levosulpiride-loaded suppositories with improved bioavailability in vivo.
    Fakhar-Ud-Din ; Khan GM
    Pharm Dev Technol; 2019 Jan; 24(1):63-69. PubMed ID: 29251521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid quantification of levosulpiride in human plasma using RP-HPLC-MS/MS for pharmacokinetic and bioequivalence study.
    Park JH; Park YS; Rhim SY; Kim HJ; Jhee OH; Lee YS; Lee MH; Shaw LM; Kang JS
    Biomed Chromatogr; 2009 Dec; 23(12):1350-6. PubMed ID: 19488984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, characterization, in vitro and in vivo evaluation of castor oil based self-nano emulsifying levosulpiride delivery systems.
    Poorani G; Uppuluri S; Uppuluri KB
    J Microencapsul; 2016 Sep; 33(6):535-543. PubMed ID: 27599558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
    Hietala J; Syvälahti E; Röyttä M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):247-58. PubMed ID: 2526352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemistry and pharmacology of benzamides].
    Boyer P
    Sem Hop; 1983 Mar; 59(12):832-5. PubMed ID: 6306780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology of sulpiride--a dopamine receptor antagonist.
    O'Connor SE; Brown RA
    Gen Pharmacol; 1982; 13(3):185-93. PubMed ID: 7047291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereoisomers of sulpiride and dopamine: interaction on kidney function in humans].
    Agnoli GC; Cacciari M; Cariani A; Garutti C; Ikonomu E; Lenzi P
    Cardiologia; 1983 Jun; 28(6):489-508. PubMed ID: 6687180
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat.
    Cudennec A; Fage D; Bénavidès J; Scatton B
    Brain Res; 1997 Sep; 768(1-2):257-65. PubMed ID: 9369323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.